John G. Aunins, See Remarks at Seres Therapeutics, Inc. (MCRB), sold 85,674 shares at $7.27 ($655K) on 2018-09-17, disclosed to the SEC on 2018-09-19.
Open-market sale of $655k MCRB by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.08 | 14,279 | $115K | 17.6% |
| 2 | $8.08 | 14,279 | $115K | 17.6% |
| 3 | $7.57 | 14,279 | $108K | 16.5% |
| 4 | $7.57 | 14,279 | $108K | 16.5% |
| 5 | $7.27 | 14,279 | $104K | 15.9% |
| 6 | $7.27 | 14,279 |
| $104K |
| 15.9% |
| Total | $7.64 avg | 85,674 | $655K | 100% |
| Filing → |
| MCRB | SELL | 2018-10-16 | $170K | — | Filing → |
| MCRB | SELL | 2018-07-18 | $231K | — | Filing → |
| MCRB | SELL | 2018-06-18 | $245K | — | Filing → |